Analysts say, chemicals being considered for ban form significant part of the portfolio, both exports and domestic sales, of many players
Net impact would depend on final list of chemicals to be banned and companies' move to diversify portfolio
CRISIL says India will continue to see more of licensing collaborations and distribution tie-ups
With several products going off-patent globally, Indian firms can leverage opportunities for generics, contract manufacturing & research, says a report of Tata Strategic Management and FICCI
While Metahelix will hold 49 percent stake in the JV firm PT Metahelix Lifesciences Indonesia, the remaining will be with its local partner, Suresh Gobindram Vaswani
Monsanto India, Atul, Sharda Cropchem, Rallis India and Bayer CropScience were up 3%-18% on the BSE.